INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,281 Cr | ₹1,207 Cr | ₹1,039 Cr | ₹891 Cr | ₹780 Cr |
What is the latest Revenue of INDSWIFT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,281 Cr |
| Mar2024 | ₹1,207 Cr |
| Mar2023 | ₹1,039 Cr |
| Mar2022 | ₹891 Cr |
| Mar2021 | ₹780 Cr |
How is Revenue of INDSWIFT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,281 Cr | 6.10 | |
| Mar2024 | ₹1,207 Cr | 16.23 | |
| Mar2023 | ₹1,039 Cr | 16.54 | |
| Mar2022 | ₹891 Cr | 14.33 | |
| Mar2021 | ₹780 Cr | - | |
Compare Revenue of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,308.9 Cr | 9.4% | 9.8% | 53.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 9.4% |
9.8% |
53.3% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses